Q5140
HCPCSInj adalimumab-fkjp, 1 mg
Official HCPCS Level II long descriptor
Injection, adalimumab-fkjp, biosimilar, 1 mg
HCPCS Level II code Q5140 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj adalimumab-fkjp, 1 mg
Added to HCPCS: 2025-01-01
Nearby codes in Q5
- Q5129Inj, vegzelma, 10 mg
- Q5130Inj, fylnetra, 0.5 mg
- Q5133Inj, tofidence, 1 mg
- Q5134Inj, tyruko, 1 mg
- Q5135Inj, tyenne, 1 mg
- Q5136Inj. denosumab-bbdz, 1 mg
- Q5137Inj, wezlana, sub cu, 1 mg
- Q5138Inj, wezlana, iv, 1 mg
- Q5141Inj adalimumab-aaty, 1 mg
- Q5142Inj adalimumab-ryvk, 1 mg
- Q5143Inj adalimumab-adbm, 1 mg
- Q5144Inj, idacio, 1 mg
- Q5145Inj, abrilada, 1 mg
- Q5146Inj, hercessi, 10 mg
- Q5147Inj, aflibercept-ayyh, 1 mg
- Q5148Inj, nyposi 1 mcg
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.